This trial is withdrawn!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Growth Hormone Deficiency
and you are
between 3 and 18
years old
-
This is an observational trial.
You are contributing to medical knowledge about your condition.
Show me locations

The purpose

The purpose of this study is to investigate the long-term treatment with Zomacton® for pituitary short stature in children with insufficient growth hormone production and/or short stature caused by Turner's syndrome.

Provided treatments

  • Drug: Somatropin
Tris trial is registered with FDA with number: NCT01731028. The sponsor of the trial is Ferring Pharmaceuticals and it is looking for 0 volunteers for the current phase.
Official trial title:
Non-interventional, Observational Study of the Application of Zomacton® in the Treatment of Growth Hormone Deficiency in Routine Clinical Practice